About: http://data.cimple.eu/news-article/88b755d0cb6b52a11660b49a050d74628f18ab111132f752cb799374

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/88b755d0cb6b52a11660b49a050d74628f18ab111132f752cb799374 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	France is to begin clinical trials involving transfusions of blood plasma from coronavirus survivors into patients who have severe symptoms in a bid to treat the illness, the institutions involved said Saturday. Drugmakers are racing to develop a vaccine and treatment for the pandemic, which has killed over 60,000 people since the coronavirus first emerged in China in December. Plasma, the fluid in blood teeming with antibodies post-illness, has already proven effective in small studies to treat infectious diseases including Ebola and SARS. The French trials are to start on Tuesday, according to a joint statement from the Paris hospital authority AP-HP, the national medical research institute INSERM, and the national blood service EFS. "This clinical trial involves the transfusion of plasma from patients who have recovered from COVID-19, containing antibodies against the virus, and who could transfer this immunity to a patient suffering from COVID-19," it said. "The plasma of the people who have recovered contains these antibodies that their organisms have developed. These antibodies could help patients in an acute stage of the disease to fight the virus." The trials will involve 60 patients in Paris hospitals, half of whom will receive the plasma from the persons who have recovered. It said the first results could be known two to three weeks after the trials, The US Food and Drug Administration has alrady authorised physicians to experiment with the strategy to fight the coronavirus. Tests are also being done in China. laf/rh/wdb/txw
schema:headline	France to test plasma of coronavirus survivors to treat sick
schema:mentions	Hospital Authority Blood transfusion Clinical trial Blood plasma French language Antibody Ebola virus disease Immune system Paris Pandemic France Vaccine China Coronavirus Severe acute respiratory syndrome coronavirus 2 NHS Blood and Transplant Encrypting File System Assistance Publique – Hôpitaux de Paris Inserm Plasmapheresis
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-04-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	81 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software